Cimetropium Bromide

Alchem International with 75 years of experience in the phytochemical space has been diligent ly providing plant derived ingredients, active pharmaceutical ingredients and bulk drugs to all international significant geographies.

The success of the company’s operations lie in its proprietary manufacturing processes, intensive research, willingness to combat new challenges, mesh with evolving technologies, focussed expansion and credible response  to international validations and inspections.

The production sites are US FDA approved and WHO and EU GMP certified. The company has filed ASMF/DMFs in over 20 countries worldwide. Value additions through bio-technology, semi-synthesis and foot prints in the formulation space have happened in planned progression. Alchem’s interest in skin care is a logical part of this dimensional growth.

Sheer Quality drives Alchem’s operations

Through perfect blend of science and nature, dedicated research, selection of finest botanical herbal extracts and focused technology, Alchem has successfully extracted the potent active molecules in the plant and offers it for pharmaceutical use to help various companies spread wellness.

Cimetropium Bromide
"For pharmaceutical use, Alchem offers Cimetropium Bromide with all its inherent benefits"

Scopolamine or hyoscine is a tropane alkaloid drug with muscarinic antagonist effects. It is among the secondary metabolites of plants from Solanaceae (nightshade) family of plants, such as henbane, jimson weed (Datura), angel's trumpets (Brugmansia), and corkwood (Duboisia). Cimetropium bromide is a semi-synthetic derivative of hyoscine that is derived from the purified extract of the Australian native Duboisia Bush. It is classified as an antimuscarinic compound with antispasmodic and anticholinergic properties.

Cimetropium bromide is a quaternary ammonium compound chemically related to hyoscine butylbromide. It has high affinity for muscarinic receptors and its antispasmodic activity is due to competition with acetylcholine for the muscarinic receptors of the gastrointestinal tract smooth muscle. Blockage of the muscarinic receptors in the GI tract is the basis for its use in the treatment of abdominal pain secondary to cramping.

Cimetropium Bromide is indicated for the treatment of pain associated with gastro-intestinal spasm, for long term treatment of Irritable Bowel Syndrome (IBS) and as pre-endoscopic medication.

The product addresses broad spectrum physiological concerns and has the band width and capabilities to meet expectations. Regular use should exhibit demonstrable results to inhibit various health related issues.